DENTSPLY SIRONA Inc 8-K, filed Sep 13, 2023
DENTSPLY SIRONA Inc. (XRAY)
8-K
2023-09-13
For: 2023-09-10
View Original
Added on
April 11, 2026
About this 8-K
DENTSPLY SIRONA Inc filed this 8-K on September 13, 2023, reporting on events of September 10, 2023.
Items reported
- Item 8.01: Other events
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
(Address of Principal Executive Offices) | (Zip Code) | |||||||||||||
(844) 848-0137
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Item 8.01. Other Events.
On September 10, 2023, DENTSPLY SIRONA Inc. (the “Company”) entered into a settlement and release agreement (the “Settlement Agreement”) with Donald M. Casey Jr., the Company’s former Chief Executive Officer, pursuant to which the Company and Mr. Casey agreed to terms related to Mr. Casey’s previously disclosed separation from the Company announced on April 19, 2022. Under the terms of the Settlement Agreement, the parties agreed to the following, among other things:
•In consideration for the mutual release of claims, Mr. Casey acknowledges he has already received all accrued obligations and all amounts payable and owing, with no additional monetary consideration;
•The Company agrees not to seek clawback or recoupment of compensation already paid to Mr. Casey under the Company’s compensation recoupment policy, unless required by a regulatory agency, court order or if Mr. Casey breaches the Settlement Agreement; and
•The Company agrees to facilitate indemnification and advancement of legal fees for Mr. Casey, including as required under the indemnification agreement dated February 14, 2018 between the Company and Mr. Casey, the form of which was attached as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed February 15, 2018, and the Company agrees not to object to such indemnification to the extent consistent with the Company’s charter, bylaws and applicable law.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DENTSPLY SIRONA Inc.
| By: | /s/ Richard C. Rosenzweig | |||||||
| Richard C. Rosenzweig | ||||||||
| Senior Vice President, Corporate Development, | ||||||||
| General Counsel and Secretary | ||||||||
Date: September 13, 2023